These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30617074)

  • 1. Computer simulations suggest that prostate enlargement due to benign prostatic hyperplasia mechanically impedes prostate cancer growth.
    Lorenzo G; Hughes TJR; Dominguez-Frojan P; Reali A; Gomez H
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1152-1161. PubMed ID: 30617074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer?
    Delongchamps NB; de la Roza G; Chandan V; Jones R; Sunheimer R; Threatte G; Jumbelic M; Haas GP
    J Urol; 2008 May; 179(5):1736-40. PubMed ID: 18343414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
    Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
    J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of human benign prostatic hyperplasia with age.
    Berry SJ; Coffey DS; Walsh PC; Ewing LL
    J Urol; 1984 Sep; 132(3):474-9. PubMed ID: 6206240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of bladder urothelial tumors in male patients--the influences of benign prostatic hyperplasia/benign prostatic enlargement.
    Zhang NZ; Chen J; Ma L; Xu ZS
    Urol Oncol; 2012 Sep; 30(5):646-51. PubMed ID: 20870428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.
    Al-Khalil S; Boothe D; Durdin T; Sunkara S; Watkins P; Yang S; Haynes A; de Riese W
    Int Urol Nephrol; 2016 Jan; 48(1):91-7. PubMed ID: 26590832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma.
    Oyasu R; Bahnson RR; Nowels K; Garnett JE
    J Urol; 1986 May; 135(5):959-62. PubMed ID: 2421020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a relationship between benign prostatic hyperplasia and prostatic cancer?
    Pagano F; Zattoni F; Vianello F; Piazza R; Capitanio G
    Eur Urol; 1991; 20 Suppl 1():31-5. PubMed ID: 1722159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphogenesis of benign prostatic hyperplasia and prostatic carcinoma].
    Bonkhoff H; Remberger K
    Pathologe; 1998 Jan; 19(1):12-20. PubMed ID: 9541938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
    Gu K; Mes-Masson AM; Gauthier J; Saad F
    Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of tissue mechanical characteristics to distinguish between benign and malignant prostatic disease.
    Phipps S; Yang TH; Habib FK; Reuben RL; McNeill SA
    Urology; 2005 Aug; 66(2):447-50. PubMed ID: 16098374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does transurethral microwave thermotherapy have a different effect on prostate cancer than on benign or hyperplastic tissue?
    Khair AA; Pacelli A; Iczkowski KA; Cheng L; Corica FA; Larson TR; Corica A; Bostwick DG
    Urology; 1999 Jul; 54(1):67-72. PubMed ID: 10414729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic adenocarcinoma with atrophic features: malignancy mimicking a benign process.
    Egan AJ; Lopez-Beltran A; Bostwick DG
    Am J Surg Pathol; 1997 Aug; 21(8):931-5. PubMed ID: 9255256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
    Hussein MR; Al-Assiri M; Musalam AO
    Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histology of specimens taken by prostatectomy and needle biopsy.
    Ngugi PM; Byakika B
    East Afr Med J; 2007 Aug; 84(8):363-6. PubMed ID: 17970003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.